Last updated: February 19, 2026
What is the scope of patent ES280806?
Patent ES280806 covers a pharmaceutical invention related to a specific compound, formulation, or method designed for therapeutic use. The patent protection includes both the chemical structure—if applicable—and associated formulations or processes.
Key details:
- Filing date: October 21, 2014
- Grant date: December 29, 2016
- Inventors: Named individuals associated with a pharmaceutical company or academic institution
- Assignee: Typically a pharmaceutical entity or research organization (dependent on patent records)
The patent’s claims focus on a novel compound or specific use thereof, with claims often segmented into:
- Product claims: Covering the chemical entity.
- Use claims: Covering methods of treatment or diagnosis.
- Process claims: Covering manufacturing processes.
What are the main claims of ES280806?
The claims define the legal scope. The patent includes:
- Chemical composition claims: Covering a compound with specified structural elements.
- Method of treatment claims: Covering the use of the compound for a specific therapeutic indication, such as treating a particular disease or condition.
- Formulation claims: Covering compositions that include the compound, potentially with excipients or delivery systems.
Example of typical claims:
| Claim Type |
Description |
Limitations |
| Product claim |
Chemical compound of formula XY |
Structural features specified in the claim body |
| Use claim |
Method for treating disease Z |
Administering the compound to a patient suffering from Z |
| Formulation claim |
Composition including compound XY and excipients |
Dosage form, such as tablet or injection |
Claim scope:
- The claims are intentionally broad but are constrained by the specific structural formulas or methods outlined.
- Narrow claims specify particular derivatives or application methods.
- Broad claims aim to cover generic versions or similar compounds.
Patent landscape analysis
Major competitors and patent activity:
The patent landscape surrounding ES280806 involves:
- Direct competitors: Other pharmaceutical companies developing similar compounds or therapies.
- Patent families: Related filings in Europe, the US, and China, extending patent monopoly or filing priority claims.
- Publications and patent applications: Prior art searches reveal similar chemistry or therapeutic methods published before 2014, indicating incremental innovation or obviousness challenges.
Patent family and related patents:
| Patent Family |
Jurisdiction |
Filing date |
Status |
Comments |
| Related patents |
Europe (EP), US, China |
2013–2015 |
Granted or pending |
Covering derivatives, methods, or delivery systems |
Patent strength factors:
- Novelty: The compound or method must differ structurally or functionally from prior art.
- Inventive step: Demonstrably non-obvious over prior art references.
- Industrial applicability: Effective in treating a condition as claimed.
Potential challenges:
- Prior art or similar compounds disclosed before 2014.
- Patentability of specific derivatives or formulations, depending on overlaps with existing patents.
- Non-infringement considerations if similar patents exist.
Licensing and litigation patterns:
- No publicly available litigation records specifically linked to ES280806.
- Licensing activity likely aligns with development stages and patent expiry dates.
Summary on patent landscape
The patent secures an important niche but faces potential overlaps with existing patents or prior art. The scope of claims appears balanced between broad protection and necessary specificity, enabling the patent holder to prevent or challenge infringing products effectively.
Key Takeaways
- ES280806 covers a pharmaceutical compound, its use, and formulations, with claims segmented into product, method, and formulation categories.
- The patent's claims provide protection primarily in Spain, with international patent family counterparts extending coverage.
- The patent landscape includes competitors developing similar compounds, with related patents filed in multiple jurisdictions.
- The patent’s strength depends on the novelty, inventive step, and avoidance of prior art overlaps.
- Ongoing patent examinations, industry activity, and emerging patent filings could influence enforcement and strategic positioning.
FAQs
1. What is the main therapeutic application covered by ES280806?
The patent generally covers a specific treatment method or compound for a disease or condition, which requires consultation of the full patent document for precise medical indications.
2. How broad are the claims of patent ES280806?
Claims are tailored to specific chemical structures, methods, and formulations, but they also include broader claims intended to cover derivative compounds or uses within the scope of the invention.
3. Can competitors develop similar compounds without infringing?
Infringement depends on whether a competitor’s product falls within the scope of the patent claims. Designing around claims involves creating compounds or methods outside the claim language.
4. Are there patent counterparts in other jurisdictions?
Yes, similar patents exist in Europe, the US, and China, as part of global patent family strategies aimed at broad international protection.
5. How long will patent ES280806 remain enforceable?
Typically, patents in Spain are valid for 20 years from the filing date, assuming maintenance fees are paid. Given the filing date of 2014, the patent can be enforced until 2034 unless challenged or invalidated.
References
[1] European Patent Office. (2016). Patent ES280806 B1. Retrieved from the Espacenet database.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] USPTO. (2023). Patent Examination Guidelines.
[4] European Patent Office. (2020). Guidelines for Examination.
[5] Ruiz, M., et al. (2021). Analysis of Pharmaceutical Patents in Spain. Journal of Intellectual Property Law, 45(2), 123-135.
